Evidence from 50 COVID‐19 patients and 94 age‐ and sex‐matched controls shows that SARS‐CoV‐2 serum had significantly increased sEH activity compared to age‐ and sex‐matched SARS‐CoV‐2‐negative group.40 This evidence concerns the gene EPHX2 and COVID-19.